help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agah, A.
Right arrow Articles by Bornstein, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agah, A.
Right arrow Articles by Bornstein, P.
(American Journal of Pathology. 2005;167:81-88.)
© 2005 American Society for Investigative Pathology

Proteolysis of Cell-Surface Tissue Transglutaminase by Matrix Metalloproteinase-2 Contributes to the Adhesive Defect and Matrix Abnormalities in Thrombospondin-2-Null Fibroblasts and Mice

Azin Agah, Themis R. Kyriakides and Paul Bornstein

From the Department of Biochemistry, School of Medicine, University of Washington, Seattle, Washington

Thrombospondin (TSP)-2-null dermal fibroblasts display an attachment defect that results from increased matrix metalloproteinase (MMP)-2 levels in their conditioned media. To investigate the molecular mechanisms responsible for this defect, we analyzed the activity of tissue transglutaminase (tTG) in TSP-2-null dermal fibroblasts and in tissues of TSP-2-null mice. tTG functions as a co-receptor for ß1 and ß3 integrins and stabilizes extracellular matrix proteins by introduction of isopeptide cross-links. Cell-surface tTG activity was reduced in TSP-2-null cells (0.50 ± 0.05 arbitrary units versus 0.84 ± 0.07 for wild type; P ≤ 0.05), and addition of MMP-2 to the culture medium of wild-type cells caused a 35% reduction in cell-surface tTG activity. tTG was susceptible to proteolysis by MMP-2 in vitro, and addition of the MMP inhibitor TIMP-2 to TSP-2-null cells restored tTG activity (0.3 ± 0.08 for untreated cells; 0.71 ± 0.09 with TIMP-2). TSP-2-null mice had reduced tTG activity in skin, as measured by incorporation of fluorescein isothiocyanate-labeled cadaverine, and a threefold increase in acetic acid-extracted dermal collagen. Furthermore, isopeptide cross-links were reduced in both uninjured skin and in excisional wounds of TSP-2-null mice, as determined by morphometric immunohistochemical analysis, indicating that isopeptide cross-links are important for the stabilization of the collagenous matrix in dermis. These findings provide a mechanism for the reduced adhesion of TSP-2-null fibroblasts and an explanation for the increased collagen solubility and fragility of TSP-2-null skin.





This article has been cited by other articles:


Home page
J. Cell Sci.Home page
J. C. Adams, A. A. Bentley, M. Kvansakul, D. Hatherley, and E. Hohenester
Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region
J. Cell Sci., March 15, 2008; 121(6): 784 - 795.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Song, W. Chang, S. Lim, H.-S. Seo, C. Y. Shim, S. Park, K.-J. Yoo, B.-S. Kim, B.-H. Min, H. Lee, et al.
Tissue Transglutaminase Is Essential for Integrin-Mediated Survival of Bone Marrow-Derived Mesenchymal Stem Cells
Stem Cells, June 1, 2007; 25(6): 1431 - 1438.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Vanhoutte, M. W.M. Schellings, M. Gotte, M. Swinnen, V. Herias, M. K. Wild, D. Vestweber, E. Chorianopoulos, V. Cortes, A. Rigotti, et al.
Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction
Circulation, January 30, 2007; 115(4): 475 - 482.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. R. Chade, J. D. Krier, S. C. Textor, A. Lerman, and L. O. Lerman
Endothelin-A Receptor Blockade Improves Renal Microvascular Architecture and Function in Experimental Hypercholesterolemia
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3394 - 3403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.